Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions - A report on 18 patients

被引:111
作者
Su, LD
Fullen, DR
Sondak, VK
Johnson, TM
Lowe, L
机构
[1] Univ Michigan, Med Ctr, Dept Pathol & Dermatol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Med Ctr, Dept Dermatol Otorhinolaryngol & Surg, Ann Arbor, MI 48109 USA
关键词
Spitz nevus; atypical Spitz tumor; spitzoid melanoma; sentinel lymph node;
D O I
10.1002/cncr.11074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Spindle and/or epithelioid melanocytic proliferations that display overlapping histopathologic features of Spitz nevus and Spitz-like melanoma are diagnostically difficult and controversial melanocytic tumors. There are reports of such lesions metastasizing to regional lymph nodes, with a few widely disseminating, resulting in death. METHODS. The authors reviewed clinical and histopathologic data on all patients with atypical or borderline spitzoid melanocytic proliferations who underwent sentinel lymph node biopsy (SLNB). They examined how frequently histologically problematic or borderline spitzoid melanocytic lesions metastasized to sentinel lymph nodes (SLNs) and which clinical or histologic features, if any, predisposed patients to a higher risk lesion. RESULTS. Six male patients and 12 female patients, ages 5-32 years (mean, 16 years), had tumors ranging in size from 1.2 mm to 7.9 mm (mean, 3.5 mm) in thickness. Atypical histologic features that were present most frequently included incomplete maturation (18 of 18 patients), deep dermal mitoses (16 of 18 patients), nuclear pleomorphism (10 of 18 patients), and focal sheet-like growth (10 of 18 patients). Eight of 18 patients (44%) had SLN metastasis and were offered adjuvant treatment. One of eight patients with SLN positive results who underwent regional lymphadenectomy had one additional involved lymph node. All 18 patients were alive and well with no evidence of recurrent or metastatic disease after a follow-up of 3-42 months (mean, 12 months). CONCLUSIONS. Histologically atypical or borderline spitzoid, melanocytic tumors are diagnostically challenging and controversial melanocytic lesions, some of which represent unrecognized melanomas. SLNB aids in confirming a diagnosis of melanoma and identifies patients who may benefit from early therapeutic lymph node dissection and/or adjuvant therapy.
引用
收藏
页码:499 / 507
页数:9
相关论文
共 53 条
[1]   Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].
Balch, CM ;
Soong, SJ ;
Gershenwald, JE ;
Thompson, JF ;
Reintgen, DS ;
Cascinelli, N ;
Urist, M ;
McMasters, KM ;
Ross, MI ;
Kirkwood, JM ;
Atkins, MB ;
Thompson, JA ;
Coit, DG ;
Byrd, D ;
Desmond, R ;
Zhang, YT ;
Liu, PY ;
Lyman, GH ;
Morabito, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634
[2]  
BARNHILL R, 1998, TXB DERMATOPATHOLOGY, P550
[3]   Atypical Spitz nevi/tumors: Lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome [J].
Barnhill, RL ;
Argenyi, ZB ;
From, L ;
Glass, LF ;
Maize, JC ;
Mihm, MC ;
Rabkin, MS ;
Ronan, SG ;
White, WL ;
Piepkorn, M .
HUMAN PATHOLOGY, 1999, 30 (05) :513-520
[4]  
BARNHILL RL, 1995, CANCER, V76, P1833, DOI 10.1002/1097-0142(19951115)76:10<1833::AID-CNCR2820761024>3.0.CO
[5]  
2-L
[6]   Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma [J].
Bastian, BC ;
Wesselmann, U ;
Pinkel, D ;
LeBoit, PE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) :1065-1069
[7]   MIB-1 monoclonal antibody to determine proliferative activity of Ki-67 antigen as an adjunct to the histopathologic differential diagnosis of Spitz nevi [J].
Bergman, R ;
Malkin, L ;
Sabo, E ;
Kerner, H .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (03) :500-504
[8]   MALIGNANT-MELANOMA IN CHILDREN AND YOUNG-ADULTS - EFFECT OF DIAGNOSTIC CRITERIA ON STAGING AND END RESULTS [J].
BODDIE, AW ;
SMITH, JL ;
MCBRIDE, CM .
SOUTHERN MEDICAL JOURNAL, 1978, 71 (09) :1074-1078
[9]   BENIGN METASTATIC CELLULAR BLUE NEVUS [J].
BORTOLANI, A ;
BARISONI, D ;
SCOMAZZONI, G .
ANNALS OF PLASTIC SURGERY, 1994, 33 (04) :426-431
[10]  
BUSAM KJ, 1995, PATHOLOGY MELANOCYTI, P97